Hematopoietic and immunologic tissue grafting. Current concepts and indications in pediatric patients.
D000741:Anemia, Aplastic / Q000601:surgery; D000818:Animals; D000917:Antibody Formation; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000506:poisoning; D016026:Bone Marrow Transplantation; D006084:Graft Rejection; D006087:Graft vs Host Reaction; D006402:Hematologic Diseases / Q000235:genetics / Q000601:surgery; D006410:Hematopoiesis; D006467:Hemophilia A / Q000601:surgery; D006648:Histocompatibility; D006801:Humans; D007108:Immune Tolerance; D007125:Immunogenetics; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007938:Leukemia / Q000601:surgery; D008221:Lymphoid Tissue / Q000637:transplantation*; D009369:Neoplasms / Q000601:surgery; D011832:Radiation Injuries / Q000601:surgery; D011878:Radiotherapy; D014181:Transplantation Immunology; D014182:Transplantation, Autologous; D014183:Transplantation, Heterologous; D014184:Transplantation, Homologous
D000961:Antilymphocyte Serum; D000970:Antineoplastic Agents; D007166:Immunosuppressive Agents